Aprea Therapeutics, Inc. (APRE) vs Alaunos Therapeutics, Inc. (TCRT)

Aprea Therapeutics, Inc. and Alaunos Therapeutics, Inc. are both Biotechnology companies. Aprea Therapeutics, Inc. and Alaunos Therapeutics, Inc. are of similar size ($6.7M and $6.3M). Alaunos Therapeutics, Inc. grew revenue faster over the last twelve months: −17.7% against −81.0%. Across the 12 metrics below, Aprea Therapeutics, Inc. leads on 7 and Alaunos Therapeutics, Inc. on 5.

Valuation

Metric APRE TCRT Biotechnology median
P/E n/m n/m 11.19
P/S 82.67 283.15 9.15
P/B 0.69 6.08 2.23
Price to free cash flow n/m n/m 26.14
EV/EBITDA 0.93 n/m 0.71
EV/Sales (49.80) 1,378.58 8.65
Earnings yield (159.00%) (118.57%) (33.82%)
Free cash flow yield (53.94%) (33.32%) (23.58%)

Profitability

Metric APRE TCRT Biotechnology median
Gross margin 100.00% 100.00% 68.27%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (62.83%) (185.95%) (50.82%)
Return on assets (53.24%) (128.30%) (46.08%)
Return on invested capital 0.00% (480.35%) 0.00%

Growth

Metric APRE TCRT Biotechnology median
Revenue growth (TTM) (80.99%) (17.65%) 7.42%
EPS growth (last fiscal year) 17.87% 24.66% 29.86%
Revenue growth, 5-year CAGR — (49.08%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APRE TCRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.67 0.77 4.72
Net debt to EBITDA 1.11 0.33 1.01

Dividend

Metric APRE TCRT Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric APRE TCRT Biotechnology median
Market cap 6.25m 6.69m 176.65m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack